HGD
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study To Determine The Maximum Range of Light Doses At Two HPPH Doses With Acceptable Normal Tissue Toxicity For PDT Treatment Of High Grade Dysplasia,CIS or Early Adenocarcinoma In Barrett's Esophagus (NCT01238042) | Roswell Park Cancer Institute | 2003-03-01 |
Track HGD automatically
Every clearance here is in the API, with alerts when new ones post.